statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	718
SG - Singapore	210
HK - Hong Kong	98
CN - Cina	97
VN - Vietnam	84
BR - Brasile	78
IT - Italia	74
SE - Svezia	58
GB - Regno Unito	45
DE - Germania	34
FI - Finlandia	32
RU - Federazione Russa	22
MX - Messico	17
AU - Australia	13
CA - Canada	13
FR - Francia	12
AR - Argentina	11
ES - Italia	11
IN - India	11
BG - Bulgaria	10
KR - Corea	10
NL - Olanda	10
DK - Danimarca	7
ID - Indonesia	7
JP - Giappone	7
NZ - Nuova Zelanda	7
TR - Turchia	7
BD - Bangladesh	6
UZ - Uzbekistan	6
CO - Colombia	5
IQ - Iraq	5
PL - Polonia	4
ZA - Sudafrica	4
EC - Ecuador	3
JO - Giordania	3
NO - Norvegia	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
IL - Israele	2
IR - Iran	2
PH - Filippine	2
PK - Pakistan	2
SA - Arabia Saudita	2
UA - Ucraina	2
VE - Venezuela	2
BB - Barbados	1
BY - Bielorussia	1
CL - Cile	1
CR - Costa Rica	1
DZ - Algeria	1
EG - Egitto	1
GH - Ghana	1
IE - Irlanda	1
JM - Giamaica	1
KW - Kuwait	1
LT - Lituania	1
MA - Marocco	1
MO - Macao, regione amministrativa speciale della Cina	1
MY - Malesia	1
NI - Nicaragua	1
PE - Perù	1
SI - Slovenia	1
SY - Repubblica araba siriana	1
Totale	1.778

Nome	#
The negative impact of most relevant infections on fertility and Assisted Reproduction Technology	205
The complex relationship between female age and embryo euploidy	205
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays	182
Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation	181
The predicted probability of live birth in In Vitro Fertilization varies during important stages throughout the treatment: analysis of 114,882 first cycles	179
Progestins for pituitary suppression during ovarian stimulation for ART: A comprehensive and systematic review including meta-analyses	178
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?	163
Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone	141
The interchangeability of two assays for the measurement of anti-Müllerian hormone when personalizing the dose of FSH in in-vitro fertilization cycles	140
Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS	140
The use of oral GnRH antagonists to inhibit the LH surge in women undergoing ovarian stimulation for in vitro fertilization	79
Totale	1.793

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	28	0	0	0	0	0	0	0	0	0	11	3	14
2021/2022	218	7	62	1	4	2	8	17	9	12	12	60	24
2022/2023	160	26	33	27	4	6	11	0	11	16	1	7	18
2023/2024	146	2	8	6	17	23	2	24	25	8	3	1	27
2024/2025	398	8	0	9	21	81	53	25	19	42	46	35	59
2025/2026	755	78	29	72	93	110	52	119	49	90	63	0	0
Totale													1.793